| Product Code: ETC7747645 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Japan continued to heavily rely on imports of rituximab, with top exporting countries being Singapore, Taiwan, Lithuania, Belgium, and Ireland. The High Herfindahl-Hirschman Index (HHI) indicates a concentrated market, underscoring the dominance of these key exporters. Despite a modest Compound Annual Growth Rate (CAGR) of 4.63% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 at -14.56%. This fluctuation suggests a need for market monitoring and strategic adjustments to navigate changing dynamics in the rituximab import landscape in Japan.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Rituximab Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Rituximab Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Rituximab Market - Industry Life Cycle |
3.4 Japan Rituximab Market - Porter's Five Forces |
3.5 Japan Rituximab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Japan Rituximab Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Rituximab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Japan |
4.2.2 Growing adoption of rituximab for the treatment of various cancers |
4.2.3 Rising geriatric population in Japan leading to higher demand for rituximab therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of rituximab in Japan |
4.3.2 High cost associated with rituximab treatment limiting accessibility |
4.3.3 Competition from alternative therapies and biosimilar rituximab products |
5 Japan Rituximab Market Trends |
6 Japan Rituximab Market, By Types |
6.1 Japan Rituximab Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Japan Rituximab Market Revenues & Volume, By Route of Administration, 2021- 2031F |
6.1.3 Japan Rituximab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.1.4 Japan Rituximab Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.1.5 Japan Rituximab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2 Japan Rituximab Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Japan Rituximab Market Revenues & Volume, By Non-Hodgkin's Lymphoma, 2021- 2031F |
6.2.3 Japan Rituximab Market Revenues & Volume, By Chronic Lymphocytic Leukemia, 2021- 2031F |
6.2.4 Japan Rituximab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.2.5 Japan Rituximab Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Rituximab Market Import-Export Trade Statistics |
7.1 Japan Rituximab Market Export to Major Countries |
7.2 Japan Rituximab Market Imports from Major Countries |
8 Japan Rituximab Market Key Performance Indicators |
8.1 Patient adherence rate to rituximab therapy |
8.2 Number of clinical trials evaluating new indications for rituximab in Japan |
8.3 Rate of adoption of rituximab in different healthcare facilities |
8.4 Average time from diagnosis to initiation of rituximab treatment |
8.5 Patient-reported outcomes and quality of life improvements post rituximab therapy |
9 Japan Rituximab Market - Opportunity Assessment |
9.1 Japan Rituximab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Japan Rituximab Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Rituximab Market - Competitive Landscape |
10.1 Japan Rituximab Market Revenue Share, By Companies, 2024 |
10.2 Japan Rituximab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here